0.014325
0.000000
0.000000
0.000000
0.011818
0.000000
0.000000
0.000000
0.010332
0.00000
0.00000
0.00000
Rotonda, J.
Becker, J.W.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
69.810
84.620
96.790
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H9 N O3
119.119
(3S)-3-amino-4-hydroxybutanoic acid
peptide-like
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
3
619
625
10.1038/nsb0796-619
8673606
The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis.
1996
UK
Nature
NATUAS
0006
0028-0836
376
37
Identification and Inhibition of the Ice/Ced-3 Protease Necessary for Mammalian Apoptosis
1995
10.2210/pdb1pau/pdb
pdb_00001pau
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
293
1
AREA DETECTOR
1995-11-09
SIEMENS
GRAPHITE(002)
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
RIGAKU RUH2R
16639.902
APOPAIN
3.4.22.-
1
man
polymer
11910.604
APOPAIN
3.4.22.-
1
man
polymer
488.489
ACE-ASP-GLU-VAL-ASJ
1
syn
polymer
18.015
water
34
nat
water
CASPASE-3, CPP32, YAMA
CASPASE-3, CPP32, YAMA
no
no
SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDH
SKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETD
SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDH
SKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETD
A
polypeptide(L)
no
no
SGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDAT
FHAKKQIPCIVSMLTKELYFYH
SGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDAT
FHAKKQIPCIVSMLTKELYFYH
B
polypeptide(L)
no
yes
(ACE)DEV(ASJ)
XDEVX
C
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
1
2.47
51.
VAPOR DIFFUSION, HANGING DROP
5.0
HANGING DROP VAPOR DIFFUSION. 1.5 MICROLITER DROPS OF PROTEIN:INHIBITOR SOLUTION (8.7 MG/ML IN 10 MILLIMOLAR TRIS-HCL PH 8.5, 10 MILLIMOLAR DTT, 3 MILLIMOLAR SODIUM AZIDE) WERE MIXED WITH AN EQUAL VOLUME OF RESERVOIR BUFFER (7% PEG-6000 (W/W), 0.10 MOLAR SODIUM CITRATE PH 5.0, 10 MILLIMOLAR DTT, 3 MILLIMOLAR SODIUM AZIDE) AND INCUBATED AT ROOM TEMPERATURE, vapor diffusion - hanging drop
5.0-8.0
pdbx_database_status
struct_conf
struct_conf_type
database_2
pdbx_initial_refinement_model
struct_conn
repository
Initial release
Version format compliance
Atomic model
Database references
Derived calculations
Non-polymer description
Structure summary
Version format compliance
Other
Derived calculations
Other
Database references
Derived calculations
Refinement description
1
0
1997-07-07
1
1
2008-03-24
1
2
2011-07-13
1
3
2012-12-12
1
4
2017-11-29
1
5
2023-08-09
_pdbx_database_status.process_site
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_conn.pdbx_dist_value
_struct_conn.pdbx_leaving_atom_flag
_struct_conn.ptnr1_auth_asym_id
_struct_conn.ptnr1_auth_comp_id
_struct_conn.ptnr1_auth_seq_id
_struct_conn.ptnr1_label_asym_id
_struct_conn.ptnr1_label_atom_id
_struct_conn.ptnr1_label_comp_id
_struct_conn.ptnr1_label_seq_id
_struct_conn.ptnr2_auth_comp_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_atom_id
_struct_conn.ptnr2_label_comp_id
_struct_conn.ptnr2_label_seq_id
Y
BNL
1996-06-06
REL
REL
HOH
water
THE INHIBITOR IS COVALENTLY CONNECTED TO CYS OF THE ENZYME TO FORM A HEMITHIOKETAL.
AMINO ACID RESIDUES ARE NUMBERED TO FACILITATE COMPARISON
WITH THE INTERLEUKIN 1-BETA CONVERTING ENZYME (ICE, PDB
ENTRY 1ICE). RESIDUES IN APOPAIN ARE ASSIGNED THE NUMBERS
OF THE HOMOLOGOUS RESIDUES IN THE ALIGNED THREE-DIMENSIONAL
STRUCTURE OF ICE. APOPAIN SEQUENCE NUMBERS ARE OMITTED
WHEN NO ICE-RELATED RESIDUE IS PRESENT IN APOPAIN, AND
APOPAIN-SPECIFIC INSERTIONS ARE INDICATED BY THE ADDITION
OF LETTERS TO THE ICE SEQUENCE NUMBERS.
1ICE
PROTEIN COMPONENT OF INTERLEUKIN-1BETA CONVERTING ENZYME (PDB ENTRY 1ICE)
PDB
experimental model
Inhibitor
Ac-Asp-Glu-Val-Asp-Aldehyde
Peptide-like
HOH
601
4
HOH
HOH
601
A
HOH
602
4
HOH
HOH
602
A
HOH
606
4
HOH
HOH
606
A
HOH
609
4
HOH
HOH
609
A
HOH
611
4
HOH
HOH
611
A
HOH
615
4
HOH
HOH
615
A
HOH
617
4
HOH
HOH
617
A
HOH
620
4
HOH
HOH
620
A
HOH
621
4
HOH
HOH
621
A
HOH
624
4
HOH
HOH
624
A
HOH
625
4
HOH
HOH
625
A
HOH
627
4
HOH
HOH
627
A
HOH
628
4
HOH
HOH
628
A
HOH
630
4
HOH
HOH
630
A
HOH
631
4
HOH
HOH
631
A
HOH
632
4
HOH
HOH
632
A
HOH
633
4
HOH
HOH
633
A
HOH
634
4
HOH
HOH
634
A
HOH
603
4
HOH
HOH
603
B
HOH
604
4
HOH
HOH
604
B
HOH
605
4
HOH
HOH
605
B
HOH
607
4
HOH
HOH
607
B
HOH
608
4
HOH
HOH
608
B
HOH
610
4
HOH
HOH
610
B
HOH
612
4
HOH
HOH
612
B
HOH
613
4
HOH
HOH
613
B
HOH
614
4
HOH
HOH
614
B
HOH
616
4
HOH
HOH
616
B
HOH
618
4
HOH
HOH
618
B
HOH
622
4
HOH
HOH
622
B
HOH
623
4
HOH
HOH
623
B
HOH
626
4
HOH
HOH
626
B
HOH
629
4
HOH
HOH
629
B
HOH
619
4
HOH
HOH
619
C
n
1
145
A
n
2
146
A
n
3
147
A
n
4
148
A
n
5
149
A
ASP
150
n
6
ASP
150
A
ASN
151
n
7
ASN
151
A
SER
152
n
8
SER
152
A
TYR
153
n
9
TYR
153
A
LYS
154
n
10
LYS
154
A
MET
155
n
11
MET
155
A
ASP
156
n
12
ASP
156
A
TYR
156
n
13
A
TYR
156
A
PRO
161
n
14
PRO
161
A
GLU
162
n
15
GLU
162
A
MET
162
n
16
A
MET
162
A
GLY
163
n
17
GLY
163
A
LEU
164
n
18
LEU
164
A
CYS
165
n
19
CYS
165
A
ILE
166
n
20
ILE
166
A
ILE
167
n
21
ILE
167
A
ILE
168
n
22
ILE
168
A
ASN
169
n
23
ASN
169
A
ASN
170
n
24
ASN
170
A
LYS
171
n
25
LYS
171
A
ASN
172
n
26
ASN
172
A
PHE
173
n
27
PHE
173
A
HIS
174
n
28
HIS
174
A
LYS
175
n
29
LYS
175
A
SER
175
n
30
A
SER
175
A
THR
175
n
31
B
THR
175
A
GLY
175
n
32
C
GLY
175
A
MET
176
n
33
MET
176
A
THR
177
n
34
THR
177
A
SER
178
n
35
SER
178
A
ARG
179
n
36
ARG
179
A
SER
180
n
37
SER
180
A
GLY
181
n
38
GLY
181
A
THR
182
n
39
THR
182
A
ASP
183
n
40
ASP
183
A
VAL
184
n
41
VAL
184
A
ASP
185
n
42
ASP
185
A
ALA
186
n
43
ALA
186
A
ALA
187
n
44
ALA
187
A
ASN
188
n
45
ASN
188
A
LEU
189
n
46
LEU
189
A
ARG
190
n
47
ARG
190
A
GLU
191
n
48
GLU
191
A
THR
192
n
49
THR
192
A
PHE
193
n
50
PHE
193
A
ARG
194
n
51
ARG
194
A
ASN
195
n
52
ASN
195
A
LEU
196
n
53
LEU
196
A
LYS
197
n
54
LYS
197
A
TYR
198
n
55
TYR
198
A
GLU
199
n
56
GLU
199
A
VAL
200
n
57
VAL
200
A
ARG
201
n
58
ARG
201
A
ASN
202
n
59
ASN
202
A
LYS
203
n
60
LYS
203
A
ASN
204
n
61
ASN
204
A
ASP
205
n
62
ASP
205
A
LEU
206
n
63
LEU
206
A
THR
207
n
64
THR
207
A
ARG
208
n
65
ARG
208
A
GLU
209
n
66
GLU
209
A
GLU
210
n
67
GLU
210
A
ILE
211
n
68
ILE
211
A
VAL
212
n
69
VAL
212
A
GLU
213
n
70
GLU
213
A
LEU
214
n
71
LEU
214
A
MET
215
n
72
MET
215
A
ARG
216
n
73
ARG
216
A
ASP
217
n
74
ASP
217
A
VAL
218
n
75
VAL
218
A
SER
219
n
76
SER
219
A
LYS
220
n
77
LYS
220
A
GLU
221
n
78
GLU
221
A
ASP
222
n
79
ASP
222
A
HIS
224
n
80
HIS
224
A
SER
225
n
81
SER
225
A
LYS
226
n
82
LYS
226
A
ARG
227
n
83
ARG
227
A
SER
228
n
84
SER
228
A
SER
229
n
85
SER
229
A
PHE
230
n
86
PHE
230
A
VAL
231
n
87
VAL
231
A
CYS
232
n
88
CYS
232
A
VAL
233
n
89
VAL
233
A
LEU
234
n
90
LEU
234
A
LEU
235
n
91
LEU
235
A
SER
236
n
92
SER
236
A
HIS
237
n
93
HIS
237
A
GLY
238
n
94
GLY
238
A
GLU
239
n
95
GLU
239
A
GLU
240
n
96
GLU
240
A
GLY
241
n
97
GLY
241
A
ILE
242
n
98
ILE
242
A
ILE
243
n
99
ILE
243
A
PHE
244
n
100
PHE
244
A
GLY
245
n
101
GLY
245
A
THR
246
n
102
THR
246
A
ASN
247
n
103
ASN
247
A
GLY
254
n
104
GLY
254
A
PRO
255
n
105
PRO
255
A
VAL
256
n
106
VAL
256
A
ASP
257
n
107
ASP
257
A
LEU
258
n
108
LEU
258
A
LYS
259
n
109
LYS
259
A
LYS
260
n
110
LYS
260
A
ILE
261
n
111
ILE
261
A
THR
262
n
112
THR
262
A
ASN
263
n
113
ASN
263
A
PHE
264
n
114
PHE
264
A
PHE
265
n
115
PHE
265
A
ARG
266
n
116
ARG
266
A
GLY
267
n
117
GLY
267
A
ASP
268
n
118
ASP
268
A
ARG
269
n
119
ARG
269
A
CYS
270
n
120
CYS
270
A
ARG
271
n
121
ARG
271
A
SER
272
n
122
SER
272
A
LEU
273
n
123
LEU
273
A
THR
274
n
124
THR
274
A
GLY
275
n
125
GLY
275
A
LYS
276
n
126
LYS
276
A
PRO
277
n
127
PRO
277
A
LYS
278
n
128
LYS
278
A
LEU
279
n
129
LEU
279
A
PHE
280
n
130
PHE
280
A
ILE
281
n
131
ILE
281
A
ILE
282
n
132
ILE
282
A
GLN
283
n
133
GLN
283
A
ALA
284
n
134
ALA
284
A
CYS
285
n
135
CYS
285
A
ARG
286
n
136
ARG
286
A
GLY
287
n
137
GLY
287
A
THR
288
n
138
THR
288
A
GLU
289
n
139
GLU
289
A
LEU
290
n
140
LEU
290
A
ASP
291
n
141
ASP
291
A
CYS
292
n
142
CYS
292
A
GLY
293
n
143
GLY
293
A
ILE
294
n
144
ILE
294
A
GLU
295
n
145
GLU
295
A
n
146
296
A
n
147
297
A
n
1
310
B
n
2
311
B
n
3
312
B
n
4
313
B
n
5
314
B
n
6
315
B
n
7
316
B
n
8
317
B
n
9
318
B
n
10
319
B
LYS
320
n
11
LYS
320
B
ILE
321
n
12
ILE
321
B
PRO
322
n
13
PRO
322
B
VAL
323
n
14
VAL
323
B
GLU
324
n
15
GLU
324
B
ALA
325
n
16
ALA
325
B
ASP
326
n
17
ASP
326
B
PHE
327
n
18
PHE
327
B
LEU
328
n
19
LEU
328
B
TYR
329
n
20
TYR
329
B
ALA
330
n
21
ALA
330
B
TYR
331
n
22
TYR
331
B
SER
332
n
23
SER
332
B
THR
333
n
24
THR
333
B
ALA
334
n
25
ALA
334
B
PRO
335
n
26
PRO
335
B
GLY
336
n
27
GLY
336
B
TYR
337
n
28
TYR
337
B
TYR
338
n
29
TYR
338
B
SER
339
n
30
SER
339
B
TRP
340
n
31
TRP
340
B
ARG
341
n
32
ARG
341
B
ASN
342
n
33
ASN
342
B
SER
343
n
34
SER
343
B
LYS
344
n
35
LYS
344
B
ASP
345
n
36
ASP
345
B
GLY
346
n
37
GLY
346
B
SER
347
n
38
SER
347
B
TRP
348
n
39
TRP
348
B
PHE
349
n
40
PHE
349
B
ILE
350
n
41
ILE
350
B
GLN
351
n
42
GLN
351
B
SER
352
n
43
SER
352
B
LEU
353
n
44
LEU
353
B
CYS
354
n
45
CYS
354
B
ALA
355
n
46
ALA
355
B
MET
356
n
47
MET
356
B
LEU
357
n
48
LEU
357
B
LYS
358
n
49
LYS
358
B
GLN
359
n
50
GLN
359
B
TYR
360
n
51
TYR
360
B
ALA
361
n
52
ALA
361
B
ASP
362
n
53
ASP
362
B
LYS
363
n
54
LYS
363
B
LEU
364
n
55
LEU
364
B
GLU
365
n
56
GLU
365
B
PHE
366
n
57
PHE
366
B
MET
367
n
58
MET
367
B
HIS
368
n
59
HIS
368
B
ILE
369
n
60
ILE
369
B
LEU
370
n
61
LEU
370
B
THR
371
n
62
THR
371
B
ARG
372
n
63
ARG
372
B
VAL
373
n
64
VAL
373
B
ASN
374
n
65
ASN
374
B
ARG
375
n
66
ARG
375
B
LYS
376
n
67
LYS
376
B
VAL
377
n
68
VAL
377
B
ALA
378
n
69
ALA
378
B
THR
379
n
70
THR
379
B
GLU
379
n
71
A
GLU
379
B
PHE
380
n
72
PHE
380
B
GLU
381
n
73
GLU
381
B
SER
381
n
74
A
SER
381
B
PHE
381
n
75
B
PHE
381
B
SER
381
n
76
C
SER
381
B
PHE
381
n
77
D
PHE
381
B
ASP
381
n
78
E
ASP
381
B
ALA
381
n
79
F
ALA
381
B
THR
381
n
80
G
THR
381
B
PHE
381
n
81
H
PHE
381
B
HIS
381
n
82
I
HIS
381
B
ALA
382
n
83
ALA
382
B
LYS
383
n
84
LYS
383
B
LYS
384
n
85
LYS
384
B
GLN
385
n
86
GLN
385
B
ILE
386
n
87
ILE
386
B
PRO
387
n
88
PRO
387
B
CYS
388
n
89
CYS
388
B
ILE
389
n
90
ILE
389
B
VAL
390
n
91
VAL
390
B
SER
392
n
92
SER
392
B
MET
393
n
93
MET
393
B
LEU
394
n
94
LEU
394
B
THR
395
n
95
THR
395
B
LYS
396
n
96
LYS
396
B
GLU
397
n
97
GLU
397
B
LEU
398
n
98
LEU
398
B
TYR
399
n
99
TYR
399
B
PHE
400
n
100
PHE
400
B
TYR
401
n
101
TYR
401
B
n
102
402
B
ACE
501
n
1
ACE
501
C
ASP
502
n
2
ASP
502
C
GLU
503
n
3
GLU
503
C
VAL
504
n
4
VAL
504
C
ASJ
505
n
5
ASJ
505
C
author_and_software_defined_assembly
PISA
3
trimeric
software_defined_assembly
PISA
12
dodecameric
software_defined_assembly
PISA
6
hexameric
5390
-31
10940
33490
-177
31800
15180
-83
17460
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
2_675
-x+1,-y+2,z
crystal symmetry operation
69.8100000000
169.2400000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
3_655
-x+1,y,-z
crystal symmetry operation
69.8100000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
4_575
x,-y+2,-z
crystal symmetry operation
0.0000000000
169.2400000000
0.0000000000
A
N
ARG
201
A
N
ARG
58
A
O
CYS
165
A
O
CYS
19
A
N
ILE
166
A
N
ILE
20
A
O
VAL
231
A
O
VAL
87
A
N
CYS
232
A
N
CYS
88
A
O
LEU
279
A
O
LEU
129
A
N
PHE
280
A
N
PHE
130
B
O
LEU
328
B
O
LEU
19
B
N
TYR
329
B
N
TYR
20
B
O
VAL
390
B
O
VAL
91
B
N
GLY
346
B
N
GLY
37
B
O
ASN
342
B
O
ASN
33
B
N
ARG
341
B
N
ARG
32
C
O
GLU
503
C
O
GLU
3
A
N
GLU
239
A
N
GLU
95
A
O
ILE
242
A
O
ILE
98
A
N
ILE
243
A
N
ILE
99
A
O
VAL
256
A
O
VAL
106
1
A
SER
145
A
SER
1
1
Y
1
A
GLY
146
A
GLY
2
1
Y
1
A
ILE
147
A
ILE
3
1
Y
1
A
SER
148
A
SER
4
1
Y
1
A
LEU
149
A
LEU
5
1
Y
1
A
THR
296
A
THR
146
1
Y
1
A
ASP
297
A
ASP
147
1
Y
1
B
SER
310
B
SER
1
1
Y
1
B
GLY
311
B
GLY
2
1
Y
1
B
VAL
312
B
VAL
3
1
Y
1
B
ASP
313
B
ASP
4
1
Y
1
B
ASP
314
B
ASP
5
1
Y
1
B
ASP
315
B
ASP
6
1
Y
1
B
MET
316
B
MET
7
1
Y
1
B
ALA
317
B
ALA
8
1
Y
1
B
CYS
318
B
CYS
9
1
Y
1
B
HIS
319
B
HIS
10
1
Y
1
B
HIS
402
B
HIS
102
1
Y
1
A
SER
236
-177.47
-176.93
1
B
LYS
363
-143.41
-38.30
1
B
PHE
400
-102.26
42.08
PARHCSDX.PRO
TOPHCSDX.PRO
APOPAIN.PAR
APOPAIN.PRO
23.56
THERE IS NO ELECTRON DENSITY FOR RESIDUES A 145 - A 149,
A 296 - A 297, B 310 - B 319, AND B 402, PRESUMABLY DUE TO
DISORDER. MASS SPECTROMETRY INDICATES THAT THESE RESIDUES
ARE PRESENT IN THE SPECIES CRYSTALLIZED.
0.2750000
0.1950000
0.1950000
2.5
20.
845
7987
10.6
78.
RANDOM
1
FREE-R
2.
MOLECULAR REPLACEMENT
PROTEIN COMPONENT OF INTERLEUKIN-1BETA CONVERTING ENZYME (PDB ENTRY 1ICE)
2.5
20.
34
1939
0
0
1905
0.007
1.308
24.14
1.091
0.3300000
0.2570000
2.59
38
321
10.6
35.8
31.34
2.50
36.0
1PAU
8929
0.0
0.0634000
0.0555000
1
17.4
2.33
87.1
0.2570000
2.50
2.59
2.59
0.2620000
1
2.27
87.1
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
data reduction
SAINT
data scaling
SAINT
phasing
X-PLOR
3.1
Crystal structure of the complex of apopain with the tetrapeptide aldehyde inhibitor AC-DEVD-CHO
1
N
N
2
N
N
3
N
N
4
N
N
4
N
N
4
N
N
A
THR
182
A
THR
39
HELX_P
A
ASN
195
A
ASN
52
1
A
14
A
ARG
208
A
ARG
65
HELX_P
A
LYS
220
A
LYS
77
1
B
13
A
LEU
258
A
LEU
108
HELX_P
A
PHE
264
A
PHE
114
1
C
7
B
TRP
348
B
TRP
39
HELX_P
B
ALA
361
B
ALA
52
1
D
14
B
PHE
366
B
PHE
57
HELX_P
B
GLU
379
B
GLU
71
1
E
15
A
covale
1.772
one
A
CYS
285
A
SG
CYS
135
1_555
C
ASJ
505
C
C
ASJ
5
1_555
covale
1.327
both
C
ACE
501
C
C
ACE
1
1_555
C
ASP
502
C
N
ASP
2
1_555
covale
1.334
both
C
VAL
504
C
C
VAL
4
1_555
C
ASJ
505
C
N
ASJ
5
1_555
HYDROLASE/HYDROLASE INHIBITOR
CYSTEINE PROTEASE, CASPASE-3, APOPAIN, CPP32, YAMA, PROTEASE-INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
ICE3_HUMAN
UNP
1
1
P42574
SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDH
SKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETD
ICE3_HUMAN
UNP
2
1
P42574
SGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDAT
FHAKKQIPCIVSMLTKELYFYH
1PAU
PDB
3
1PAU
29
175
1PAU
145
297
P42574
A
1
1
147
176
277
1PAU
310
402
P42574
B
2
1
102
501
505
1PAU
501
505
1PAU
C
3
1
5
6
3
3
parallel
parallel
parallel
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
GLU
199
A
GLU
56
A
ASN
204
A
ASN
61
A
GLU
162
A
GLU
15
A
ASN
169
A
ASN
23
A
ARG
227
A
ARG
83
A
LEU
235
A
LEU
91
A
LYS
278
A
LYS
128
A
GLN
283
A
GLN
133
B
PHE
327
B
PHE
18
B
TYR
331
B
TYR
22
B
CYS
388
B
CYS
89
B
MET
393
B
MET
93
B
GLY
346
B
GLY
37
B
SER
347
B
SER
38
B
TRP
340
B
TRP
31
B
ASN
342
B
ASN
33
C
ASP
502
C
ASP
2
C
VAL
504
C
VAL
4
A
GLY
238
A
GLY
94
A
GLU
239
A
GLU
95
A
ILE
242
A
ILE
98
A
GLY
245
A
GLY
101
A
GLY
254
A
GLY
104
A
ASP
257
A
ASP
107
INHIBITOR BINDING SUB-SITE S1.
Unknown
10
INHIBITOR BINDING SUB-SITE S2.
Unknown
6
INHIBITOR BINDING SUB-SITE S3.
Unknown
6
INHIBITOR BINDING SUB-SITE S4.
Unknown
8
BINDING SITE FOR CHAIN C OF ACE-ASP-GLU-VAL-ASA
Software
15
A
ARG
179
A
ARG
36
10
1_555
A
SER
236
A
SER
92
10
1_555
A
HIS
237
A
HIS
93
10
1_555
A
GLY
238
A
GLY
94
10
1_555
A
GLN
283
A
GLN
133
10
1_555
A
ALA
284
A
ALA
134
10
1_555
A
CYS
285
A
CYS
135
10
1_555
B
SER
339
B
SER
30
10
1_555
B
TRP
340
B
TRP
31
10
1_555
B
ARG
341
B
ARG
32
10
1_555
A
CYS
285
A
CYS
135
6
1_555
B
TYR
338
B
TYR
29
6
1_555
B
SER
339
B
SER
30
6
1_555
B
TRP
340
B
TRP
31
6
1_555
B
ARG
341
B
ARG
32
6
1_555
B
PHE
381
B
PHE
81
H
6
1_555
A
SER
178
A
SER
35
6
1_555
A
ARG
179
A
ARG
36
6
1_555
A
SER
180
A
SER
37
6
1_555
B
TRP
340
B
TRP
31
6
1_555
B
ARG
341
B
ARG
32
6
1_555
B
SER
343
B
SER
34
6
1_555
B
TRP
340
B
TRP
31
8
1_555
B
ARG
341
B
ARG
32
8
1_555
B
ASN
342
B
ASN
33
8
1_555
B
GLY
346
B
GLY
37
8
1_555
B
SER
347
B
SER
38
8
1_555
B
TRP
348
B
TRP
39
8
1_555
B
SER
381
B
SER
74
A
8
1_555
B
PHE
381
B
PHE
75
B
8
1_555
A
SER
175
A
SER
30
A
15
2_675
A
ARG
179
A
ARG
36
15
1_555
A
HIS
237
A
HIS
93
15
1_555
A
GLN
283
A
GLN
133
15
1_555
A
CYS
285
A
CYS
135
15
1_555
B
TYR
338
B
TYR
29
15
1_555
B
SER
339
B
SER
30
15
1_555
B
TRP
340
B
TRP
31
15
1_555
B
ARG
341
B
ARG
32
15
1_555
B
ASN
342
B
ASN
33
15
1_555
B
SER
343
B
SER
34
15
1_555
B
SER
381
B
SER
74
A
15
1_555
B
PHE
381
B
PHE
75
B
15
1_555
B
HOH
626
E
HOH
15
1_555
C
HOH
619
F
HOH
15
1_555
23
I 2 2 2